<DOC>
	<DOCNO>NCT02968472</DOCNO>
	<brief_summary>A chimeric antigen receptor gene-modified T cell ( CART : 4SCAR19 ) target CD19 ( cluster differentiation antigen 19 ) , treat patient CD19 positive malignant B cell tumor , assess treatment safety , observe therapeutic effect . At time , change process CART residual tumor status patient observe dynamicallyï¼Œ summarize best therapeutic effect .</brief_summary>
	<brief_title>A Phase I Trial 4SCAR19 Cells Treatment Relapsed Refractory B Cell Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , B-Cell</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>patient age 6 month . immune phenotype analysis patient malignant B cell surface expression CD19 molecule . Karnofsky performance status score 80 point , expect patient survival time 3 month . important viscera function meet : heart ultrasound tip heart ejection fraction 50 % high , electrocardiogram ( ecg ) see obvious abnormality ; The blood oxygen saturation 90 % high ; Creatinine 2.5 time normal range less ; aspartate aminotransferase aspartate aminotransferase3 time normal range less , total bilirubin 2.0 mg/dl less . great Hgb 80 g/L . contraindication solid cell separation patient family strong willingness participate clinical trial , willing bear consequence cause test fail , sign inform consent . panel discussion , combine patient general condition , think benefit great risk involve clinical trial . accompany active disease , treatment difficult correct . bacteria , fungus , virus infection , unable control . people live HIV . active hepatitis B virus hepatitis C virus infection . pregnancy nurse mother . enter test use glucocorticoid systemic treatment within week . confirm used CAR invalid patient treat T cell , physical examination , expert discuss confirm team n't fit CAR T treatment.Before use gene therapy method . researcher believe might increase risk subject interfere test result situation .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>4 CAR-T19</keyword>
	<keyword>B cell leukemia</keyword>
	<keyword>B-ALL</keyword>
</DOC>